Skip to main content

Table 6 Non-adjusted and age/diagnosis adjusted odds ratio for pharmacological secondary prevention in men with respect to women

From: Ischemic heart disease and primary care: identifying gender-related differences. An observational study

  ORunadj C.I. 95% ORadj C.I. 95%
Any medication 1.63* (1.24–2.13) 1.43* (1.07–1.92)
Anticoagulants 1.93* (1.53–2.43) 1.81* (1.41–2.31)
Beta blockers 1.33* (1.10–1.62) 1.03 (0.84–1.27)
ACE inhibitors/ARB 1.20 (0.99–1.45) 1.15 (0.94–1.42)
Lipid-lowering agents 1.70* (1.39–2.05) 1.24* (1.01–1.53)
  1. *p-value < 0,05 in the model adjusted for age and IHD specific diagnosis (chronic ischemic heart disease, acute myocardial infarction and angina)
  2. Estimated age-adjusted OR using GAM link logit